(Q40618965)

English

Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells

scientific article published on September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

0 references

0 references

Surya P Ayalasomayajula

2

0 references

author name string

Jithan V Aukunuru

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Uday B Kompella

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1199-1206

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Novel mechanisms for antisense-mediated regulation of gene expression

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Molecular mechanisms of action of antisense drugs

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Cationic liposome-mediated transfection.

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Molecular and biological properties of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

In vivo use of oligonucleotides to inhibit choroidal neovascularisation in the eye.

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Inhibition of TGF-beta and VEGF expression in human endothelium cell lines with antisense-oligonucleotides: potential tools for gene therapy of chronic renal transplant rejection

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Synthesis and use of synthetic oligonucleotides

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Increased expression of angiogenic growth factors in age-related maculopathy

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Lasers and diabetic retinopathy: the art of gentle destruction

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Changes in the expression of transcription factors ATF-2 and Fra-2 after axotomy and during regeneration in rat retinal ganglion cells

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Current understanding on the role of retinal pigment epithelium and its pigmentation

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Antisense oligonucleotides inhibit vascular endothelial growth factor/vascular permeability factor expression in normal human epidermal keratinocytes

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Interactions between the retinal pigment epithelium and the neural retina

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Long-term outcome after photocoagulation for proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy

1 reference

https://api.crossref.org/works/10.1211%2F0022357021701

21 January 2018

Identifiers

10.1211/0022357021701

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40618965&oldid=2186028974"